Company: HBCYF
Filing Date: 2025-02-27
Form Type: 424B5
Source: 0001193125-25-039401
Chunk: 113

Company: HSBC HOLDINGS PLC
Filing Date: 2025-02-27
Form: 424B5
Chunk 113
---
itors. The underwriters are being represented by Linklaters LLP, London, England.

S-85

EXPERTS

The financial statements and management’s assessment of the effectiveness of internal control over financial reporting (which is included
in Management’s assessment of internal controls over financial reporting) incorporated in this prospectus supplement by reference to the 2024 Form 20-F have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and
accounting.

S-86

Prospectus HSBC Holdings plc Subordinated Debt Securities Senior Debt Securities Contingent Capital Securities Ordinary Shares HSBC Holdings plc may offer the following securities for sale through this prospectus (the “securities”):

| • |     | dated subordinated debt securities; |

| • |     | undated subordinated debt securities (together with the dated subordinated debt securities, the 
 “subordinated debt securities”);                                                                |

| • |     | senior debt securities (together with the subordinated debt securities, the “debt securities”); |

| • |     | contingent capital securities; and |

| • |     | ordinary shares of $0.50 nominal value each, which will be offered solely in connection with the offer of any                            
 contingent capital securities (which may be converted into ordinary shares pursuant to the terms of such contingent capital securities). |

We will provide the specific terms of the securities that we are offering in supplements to this prospectus. You should read this prospectus and any prospectus supplement carefully before you invest. This prospectus may not be used to consummate sales of debt securities, contingent capital securities or ordinary shares unless accompanied by a prospectus supplement. Our ordinary shares are listed or admitted to trading on the London Stock Exchange, the Hong Kong Stock Exchange, the New York Stock Exchange (“NYSE”) and the Bermuda Stock Exchange. Our ordinary shares listed on NYSE (under the trading symbol “HSBC”) are listed in the form of American depositary shares (“ADS”), each representing five of our ordinary shares. On February 22, 2024, the closing price of our ADSs was $37.71 per ADS on the NYSE. The debt securities and contingent capital securities will be subject to the exercise of the UK bail-inpower by the relevant UK resolution authority as described herein and in the applicable prospectus supplement for such debt securities or contingent capital securities. The debt securities and contingent capital securities